OverviewSuggest Edit

Visterra is a clinical-stage biopharmaceutical company focused on applying its novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration. It also provides a structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry.
HQWaltham, MA, US
Employee Ratings3.8

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2021)89(+2%)
Cybersecurity ratingAMore

Key People/Management at Visterra

Greg Babcock

Greg Babcock

Vice President, Research
Jean L. Bender

Jean L. Bender

Vice President, Pharmaceutical Sciences and Technology
Todd Curtis

Todd Curtis

Vice President, Finance and Controller
Chris Kiefer

Chris Kiefer

Chief Administrative Officer, General Counsel and Corporate Secretary
David Oldach

David Oldach

Chief Medical Officer
Brian J. G. Pereira

Brian J. G. Pereira

President and Chief Executive Officer
Show more

Visterra Office Locations

Visterra has an office in Waltham
Waltham, MA, US (HQ)
275 2nd Ave
Show all (1)

Visterra Financials and Metrics

Summary Metrics

Founding Date


Visterra total Funding

$125.5 m

Visterra latest funding size

$23.6 m

Time since last funding

4 years ago

Visterra investors

Visterra's latest funding round in October 2017 was reported to be $23.6 m. In total, Visterra has raised $125.5 m
Show all financial metrics

Visterra Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Visterra Online and Social Media Presence

Embed Graph

Visterra Company Culture

  • CEO Rating



  • Compensation



Learn more on Comparably

Visterra News and Updates

Biotech company Visterra scores $46.7 mln Series C

Cambridge, Massachusetts-based Visterra Inc, a biotech company, has closed its Series C funding round at $46.7 million. The investors included the Bill & Melinda Gates Foundation, MRL Ventures Fund, Vertex Venture Holdings Ltd., Polaris Partners, Flagship Pioneering, Omega Funds, Cycad Group and…

Visterra Frequently Asked Questions

  • When was Visterra founded?

    Visterra was founded in 2007.

  • Who are Visterra key executives?

    Visterra's key executives are Greg Babcock, Jean L. Bender and Todd Curtis.

  • How many employees does Visterra have?

    Visterra has 89 employees.

  • Who are Visterra competitors?

    Competitors of Visterra include Sun Pharma Advanced Research Company, Neuraxpharm and Prescient.

  • Where is Visterra headquarters?

    Visterra headquarters is located at 275 2nd Ave, Waltham.

  • Where are Visterra offices?

    Visterra has an office in Waltham.

  • How many offices does Visterra have?

    Visterra has 1 office.